Table 2.
Conventional coagulation test data and TEG-PM indicators in the hemorrhage and non-hemorrhage groups.
| Hemorrhage group (n = 21) | Non-hemorrhage group (n = 73) | P-value | |
|---|---|---|---|
| Conventional coagulation test data (mean ± SD, median IQR) | |||
| Platelet count ( × 109/L) | 191.76 (70.48) | 186.22 (99.70) | 0.813 |
| PT (sec) | 11.40 (10.05, 11.90) | 11.50 (10.80, 12.20) | 0.834 |
| PTA (%) | 92.80 (84.70, 99.50) | 96.20 (86.45, 104.65) | 0.430 |
| INR | 1.02 (0.95, 1.11) | 0.98 (0.93, 1.05) | 0.234 |
| APTT (sec) | 23.20 (19.75, 28.75) | 22.30 (19.90, 25.65) | 0.502 |
| Fib (g/L) | 2.78 (2.37, 3.97) | 2.97 (2.39, 3.42) | 0.931 |
| TT (sec) | 16.90 (15.90, 18.05) | 16.40 (15.55, 17.70) | 0.416 |
| FDP (μg/mL) | 5.07 (2.90, 15.09) | 5.74 (3.10, 25.06) | 0.435 |
| DD (μg/mL) | 1.14 (0.84, 4.26) | 1.91 (1.08, 5.47) | 0.222 |
| TEG-PM data (median IQR) | |||
| R (min) | 3.60 (3.10, 4.20) | 3.30 (2.90, 3.80) | 0.432 |
| K (min) | 1.50 (1.25, 1.70) | 1.50 (1.20, 1.90) | 0.978 |
| α Angle (deg) | 69.30 (67.85, 72.70) | 69.50 (65.40, 72.70) | 0.946 |
| MA (mm) | 62.00 (60.05, 66.70) | 62.60 (58.15, 66.15) | 0.895 |
| CI | 2.20 (1.35, 3.15) | 2.30 (1.00, 3.20) | 0.938 |
| Platelet AA pathway inhibition rate (%) | |||
| <75 (n = 67) | 10/21 (47.6) | 57/73 (78.1) | 0.014 |
| ≥75 (n = 27) | 11/21 (52.4) | 17/73 (23.3) | |
Abbreviations: AA, arachidonic acid; APTT, activated partial thromboplastin time; CI, clotting index; DD, d-dimer; Fib, fibrinogen; TT, thrombin time; FDP, fibrinogen degradation product; INR, international normalized ratio; MA, maximum amplitude; PT, prothrombin time; PTA, prothrombin activity; TEG-PM, thromboelastography with platelet mapping.